Publicaciones en colaboración con investigadores/as de Università degli Studi di Brescia (85)

2024

  1. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

    Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2

  2. Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders

    Ocular Immunology and Inflammation

  3. Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study

    Brain Communications, Vol. 6, Núm. 4

  4. Joubert syndrome-derived induced pluripotent stem cells show altered neuronal differentiation in vitro

    Cell and Tissue Research, Vol. 396, Núm. 2, pp. 255-267

  5. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results

    Alzheimer's and Dementia, Vol. 20, Núm. 5, pp. 3525-3542

  6. Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry

    Seminars in Arthritis and Rheumatism, Vol. 66

  7. Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)

    Seminars in Arthritis and Rheumatism, Vol. 65

2023

  1. A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project

    Frontiers in Medicine, Vol. 10

  2. Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository

    Arthritis and Rheumatology, Vol. 75, Núm. 8, pp. 1407-1414

  3. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study

    Laboratory investigation; a journal of technical methods and pathology, Vol. 103, Núm. 6, pp. 100147

  4. Cerebellar and subcortical atrophy contribute to psychiatric symptoms in frontotemporal dementia

    Human Brain Mapping, Vol. 44, Núm. 7, pp. 2684-2700

  5. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  6. Fluctuation of Anti–Domain 1 and Anti–β2-Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

    Arthritis and Rheumatology, Vol. 75, Núm. 6, pp. 984-995

  7. Global comment on the use of hydroxychloroquine during the periconception period and pregnancy in women with autoimmune diseases

    The Lancet Rheumatology

  8. Language impairment in the genetic forms of behavioural variant frontotemporal dementia

    Journal of Neurology, Vol. 270, Núm. 4, pp. 1976-1988

  9. Loss of brainstem white matter predicts onset and motor neuron symptoms in C9orf72 expansion carriers: a GENFI study

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1573-1586

  10. Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales

    Journal of Neurology, Vol. 270, Núm. 3, pp. 1466-1477

  11. Network structure and transcriptomic vulnerability shape atrophy in frontotemporal dementia

    Brain, Vol. 146, Núm. 1, pp. 321-336

  12. Surgeons’ perspectives on artificial intelligence to support clinical decision-making in trauma and emergency contexts: results from an international survey

    World Journal of Emergency Surgery, Vol. 18

  13. Temporal dynamics predict symptom onset and cognitive decline in familial frontotemporal dementia

    Alzheimer's and Dementia, Vol. 19, Núm. 5, pp. 1947-1962